These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 30407764)
1. Health Care Barriers to Provision of Long-Acting Reversible Contraception in Wisconsin. Olson EM; Kramer RD; Gibson C; Wautlet CK; Schmuhl NB; Ehrenthal DB WMJ; 2018 Oct; 117(4):149-155. PubMed ID: 30407764 [TBL] [Abstract][Full Text] [Related]
2. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System. Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847 [No Abstract] [Full Text] [Related]
3. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents. Davis SA; Braykov NP; Lathrop E; Haddad LB J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106 [TBL] [Abstract][Full Text] [Related]
4. Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologists. Castleberry NM; Stark L; Schulkin J; Grossman D Contraception; 2019 Aug; 100(2):123-127. PubMed ID: 30981843 [TBL] [Abstract][Full Text] [Related]
5. Are Wisconsin resident physicians trained in immediate postpartum long acting reversible contraception? Rivas K; Schmuhl NB; Taboada M; Godecker A; Brown H Contraception; 2021 Oct; 104(4):372-376. PubMed ID: 34081975 [TBL] [Abstract][Full Text] [Related]
6. Influences on Intentions to Place Long-Acting Reversible Contraceptives: A Pilot Study Comparing According to Provider Specialty in Ohio. Thompson CM; Broecker J; Dade M; Nottingham K J Pediatr Adolesc Gynecol; 2018 Oct; 31(5):509-515. PubMed ID: 29580916 [TBL] [Abstract][Full Text] [Related]
7. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education. Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553 [TBL] [Abstract][Full Text] [Related]
8. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications. ; Vricella LK; Gawron LM; Louis JM Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885 [TBL] [Abstract][Full Text] [Related]
9. Can Pediatricians Provide Long-Acting Reversible Contraception? Norris AH; Pritt NM; Berlan ED J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):39-43. PubMed ID: 30278228 [TBL] [Abstract][Full Text] [Related]
10. How Long-Acting Reversible Contraception Knowledge, Training, and Provider Concerns Predict Referrals and Placement. Thompson CM; Broecker J; Dade M J Am Osteopath Assoc; 2019 Nov; 119(11):725-734. PubMed ID: 31657827 [TBL] [Abstract][Full Text] [Related]
11. Long-acting reversible contraception knowledge, attitudes and use among HIV-infected and -uninfected women and their providers. Teodoro N; Fu A; Ohly NT; Shalev N; Matseoane-Peterssen D; Westhoff CL Contraception; 2019 Oct; 100(4):269-274. PubMed ID: 31226320 [TBL] [Abstract][Full Text] [Related]
12. Access to long-acting reversible contraception among US publicly funded health centers. Bornstein M; Carter M; Zapata L; Gavin L; Moskosky S Contraception; 2018 May; 97(5):405-410. PubMed ID: 29253581 [TBL] [Abstract][Full Text] [Related]
13. Effective, recommended, underutilized: a review of the literature on barriers to adolescent usage of long-acting reversible contraceptive methods. Coles CB; Shubkin CD Curr Opin Pediatr; 2018 Oct; 30(5):683-688. PubMed ID: 30028744 [TBL] [Abstract][Full Text] [Related]
14. IUD services among primary care practices in New York City. Jacobson L; Garbers S; Helmy H; Roobol H; Kohn JE; Kavanaugh ML Contraception; 2016 Mar; 93(3):257-62. PubMed ID: 26569447 [TBL] [Abstract][Full Text] [Related]
15. US family physicians' intrauterine and implantable contraception provision: results from a national survey. Nisen MB; Peterson LE; Cochrane A; Rubin SE Contraception; 2016 May; 93(5):432-7. PubMed ID: 26776938 [TBL] [Abstract][Full Text] [Related]
17. Projections and opinions from 100 experts in long-acting reversible contraception. Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195 [TBL] [Abstract][Full Text] [Related]
18. The Impact of an Adolescent Gynecology Provider on Intrauterine Device and Subdermal Contraceptive Implant Use Among Adolescent Patients. Crain CL; DeFruscio AE; Shah PT; Hunt L; Yoost JL J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):377-381. PubMed ID: 32087404 [TBL] [Abstract][Full Text] [Related]
19. Availability of long-acting reversible contraceptives in Los Angeles County clinics through a Medicaid state plan amendment program. Natavio M; Blotky E; Van Horn CM; Waters C; Ihenacho U; Silverstein E; Cortessis VK; Nelson AL Contraception; 2018 Dec; 98(6):471-475. PubMed ID: 30076832 [TBL] [Abstract][Full Text] [Related]
20. A Review of Long-Acting Reversible Contraception Methods and Barriers to Their Use. Baron MM; Potter B; Schrager S WMJ; 2018 Oct; 117(4):156-159. PubMed ID: 30407765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]